Protein Kinase A Inhibits Leukotriene Synthesis by Phosphorylation of 5-Lipoxygenase on Serine 523
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Leukotrienes (LTs) are lipid messengers generated by leukocytes that drive inflammation and modulate neighboring cell function. The synthesis of LTs from arachidonic acid is initiated by the enzyme 5-lipoxygenase (5-LO). We report for the first time that LT synthesis is inhibited by the direct action of protein kinase A (PKA) on 5-LO. The catalytic subunit of PKA directly phosphorylated 5-LO in vivo and in vitro and inhibited activity in intact cells and in vitro. Mutation of Ser-523 on human 5-LO prevented phosphorylation by PKA and restored LT synthesis. Treatment with PKA activators inhibited LTB(4) synthesis in 3T3 cells expressing wild type 5-LO but not in cells expressing the S523A mutant of 5-LO. The mechanism of inhibition of LTB(4) synthesis did not involve either reduced membrane association of activated 5-LO or redistribution of 5-LO from the nucleus to the cytoplasm. Instead, PKA phosphorylation of recombinant 5-LO inhibited in vitro activity, as did co-transfection of cells with 5-LO plus the catalytic subunit of PKA. Also, substitution of Ser-523 with glutamic acid, mimicking phosphorylation, resulted in the total loss of 5-LO activity. These results indicate that PKA phosphorylates 5-LO on Ser-523, which inhibits the catalytic activity of 5-LO and reduces cellular LT generation. Thus, PKA activation, as can occur in response to adenosine, prostaglandin E(2), beta-adrenergic agonists, and other mediators, is a means of directly reducing 5-LO activity and LT synthesis that may be important in limiting inflammation and maintaining homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
PROSITE: a documented database using patterns and profiles as motif descriptors
Sigrist, C. J. A. (2002) · Briefings in Bioinformatics · doi:10.1093/bib/3.3.265 · Cited by 913
Cited by
Physiology of cell volume regulation in vertebrates
Hoffmann, E. K., Lambert, I. H., & Pedersen, S. F. (2009) · Physiological Reviews · doi:10.1152/physrev.00037.2007 · Cited by 1,441
Peters-Golden, M., & Henderson, W. R. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071371 · Cited by 1,013
Self-citationLipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease
Haeggström, J. Z., & Funk, C. D. (2011) · Chemical Reviews · doi:10.1021/cr200246d · Cited by 875
Proresolving Lipid Mediators and Mechanisms in the Resolution of Acute Inflammation
Buckley, C. D., Gilroy, D. W., & Serhan, C. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.009 · Cited by 807
5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease
Rådmark, O., Werz, O., Steinhilber, D., & Samuelsson, B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.012 · Cited by 502
5-Lipoxygenase: regulation of expression and enzyme activity
Rådmark, O., Werz, O., Steinhilber, D., & Samuelsson, B. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.06.002 · Cited by 471
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
Cyclic AMP: Master Regulator of Innate Immune Cell Function
Serezani, C. H., Ballinger, M. N., Aronoff, D. M., & Peters-Golden, M. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0091tr · Cited by 415
Self-citationOld and new generation lipid mediators in acute inflammation and resolution
Stables, M. J., & Gilroy, D. W. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.005 · Cited by 334
Leukotrienes: Underappreciated Mediators of Innate Immune Responses
Peters-Golden, M., Canetti, C., Mancuso, P., & Coffey, M. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.589 · Cited by 329
Self-citationBiosynthesis and metabolism of leukotrienes
Murphy, R. C., & Gijón, M. A. (2007) · Biochemical Journal · doi:10.1042/bj20070289 · Cited by 319
Therapeutic options for 5-lipoxygenase inhibitors
Werz, O., & Steinhilber, D. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.05.009 · Cited by 260
Aronoff, D. M., Canetti, C., Serezani, C. H., Luo, M., & Peters-Golden, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.595 · Cited by 241
“Although previous studies have defined a role for PKA in mediating the suppressive effects of cAMP on LTB4 and TNF- production (20, 22), the present studies are, to our knowledge, the first to examine, and exclude, the potential involvement of Epac-1 in this setting.”
ResultSelf-citationPro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis
Zhu, M., Wang, X., Hjorth, E., Colas, R. A., Schroeder, L., Granholm, A.-C., Serhan, C. N., & Schultzberg, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9544-0 · Cited by 204
“Under certain conditions, the production of pro-inflammatory LMs can be switched to the production of pro-resolving LMs, a process termed Bclassswitching^ [43, 44].”
5-Lipoxygenase: mechanisms of regulation
Rådmark, O., & Samuelsson, B. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800062-jlr200 · Cited by 188
Pergola, C., Dodt, G., Rossi, A., Neunhoeffer, E., Lawrenz, B., Northoff, H., Samuelsson, B., Rådmark, O., Sautebin, L., & Werz, O. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809120105 · Cited by 186
5-Lipoxygenase inhibitors: a review of recent developments and patents
Pergola, C., & Werz, O. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543771003602012 · Cited by 183
“Recently, protein kinase A was reported to phosphorylate Ser-523 which impairs the catalytic activity of 5-LO [52] and also the moderate stimulation of ERK by androgens seemingly caused detrimental effects on the capacities of neutrophils to form LTs [34].”
BackgroundLipid Mediators in Inflammation
Bennett, M., & Gilroy, D. W. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0035-2016 · Cited by 172
“As well as having ‘pro-inflammatory’ properties, many prostanoids also exert immunosuppressive effects through upregulation of intracellular cAMP (85-87).”
BackgroundIncreased leukotriene E4 excretion in systemic mastocytosis
Butterfield, J. H. (2010) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2010.03.003 · Cited by 42
Metadata
- Authors
- Luo, M., Jones, S. M., Phare, S. M., Coffey, M. J., Peters-Golden, M., & Brock, T. G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-10
- Volume
- 279
- Issue
- 40
- Pages
- 41512-41520
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2056496442
- Cited by
- 135
- References
- 2
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.